Amylin, Lilly update Phase III exenatide data
AMLN and partner LLY said updated results from an open-label Phase III trial
Gathering data...
Products & Solutions
About Biocentury
Contact
Privacy & Legal
- Follow Us
Gathering data...
AMLN and partner LLY said updated results from an open-label Phase III trial